Dr. Reddy’s recalls Famotidine tablets bottles from US market

23 Oct 2017 Evaluate

Dr. Reddy’s Laboratories has initiated voluntarily recall of over half a million Famotidine tablets bottles from the US market as the drug failed impurities or degradation specifications. As many as 5,69,376 bottles of Famotidine tablets, 10 mg belonging to multiple lots packaged in 30-count, are being recalled nationwide. The drug is an over-the-counter (OTC) product used to treat and prevent ulcers in stomach and intestines.

According to a notification put up by the US Food and Drug Administration, the recall is being made under ‘Class-III’ classification, which is described as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

1325.50 11.60 (0.88%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.90
Dr. Reddys Lab 1325.50
Cipla 1329.90
Zydus Lifesciences 922.00
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×